Apopharmasp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2011-03-11
Share capital
2,000,000.00 PLN
Registered address
ul. Kinga C. Gillette 11, 94-406 Łódź, Poland
Electronic delivery address
AE:PL-91622-27543-DFAIT-23

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 12 days late).

  • 202524/06/2026
  • 202405/06/2025
  • 202310/06/2024
  • 202222/06/2023
  • 202127/07/2022
  • 202007/05/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 16%
Division · Retail trade1,360 / 9,913
Top 14%
City · Łódź496 / 8,065
Top 6.2%
Voivodeship · Łódzkie1,268 / 15,300
Top 8.3%
Country · Poland23,987 / 297,935
Top 8.1%

Results vs industry

Revenue
This companyUSD 7.55mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD -187.18kMedianUSD 20.70kAverageUSD 86.70k
Operating costs
This companyUSD 7.52mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 1.33mMedianUSD 543.65kAverageUSD 1.76m

Public procurement

Apopharma is the contractor in one public sector contract, worth USD 618.06.

SubjectAmount
Set of skincare products for packages for informal caregivers
$618.06

National Health Fund (NFZ) contracts

Apopharma has been an NFZ healthcare provider since 2019. In 2021 it is performing 3 contracts with a total value of USD 0.00. All its contracts were worth USD 0.00 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2021
Provision of medical devicespomorskie1USD 0.00
Provision of medical deviceszachodniopomorskie2USD 0.00

Authorized Representatives

Rafał Emil Jarząbek – Vice President of the Management Board
Igor Wojciech Jachorski – President of the Management Board
Paulina Świderek – Vice President of the Management Board

Manner of representation

In the event that a multi-member management board is appointed, the validity of declarations made on behalf of the company requires the joint action of two members of the management board or a member of the management board jointly with a commercial proxy.

Ownership

OwnerSharesShare valueStake
9,600$129,659.6424%
300,400$410,588.8776%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2011-09-10.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

5 public aid cases recorded, with a total value of $37,505.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$7,435
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$6,313
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$7,513

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
MybestpharmS.A.
Fragalsp. z o.o.
Modrzewscysp. j.
Ms-Pharmsp. z o.o. + limited partnership
Farmjug Agsp. z o.o.
MagmaxS.A.
Adpharmasp. z o.o.
Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j.
Pikadasp. z o.o.
Awicennasp. j.

Change history

DateEvent
2024-08-26Address change
2019-07-17PKD change
2019-06-25Address change
2016-05-30Share capital increase
2013-09-23Address change

FAQ

Last updated: 2026-06-24